FE: Analysis & Opinions

  1. After A Big Rally, Pfizer Might Need Some Rest

    May 21, 2013
    A big rally has brought Pfizer back to fair value.
  2. The Time To Buy Italy Is Now

    May 17, 2013
    Investors are getting more comfortable with owning European stocks once again. For bold investors willing to go ...
  3. Amgen Chased By The Bubble

    May 08, 2013
    Amgen really needs the pipeline to come through to support this valuation.
  4. Thermo Steps Up And Seals A Deal For Life Technologies

    April 19, 2013
    Speculation has been all over the place for an M&A with LifeTech, but the final announcement is consistent with my ...
  5. The “Healthy” Play In Contract Research Organizations

    April 17, 2013
    The pharmaceutical industry is under pressure to do more with less. That means it will be farming out many of is ...
  6. Agilent Misses, Guidance Disappoints - Analyst Blog

    February 15, 2013
    Agilent Technologies' A) fiscal first quarter earnings per share of 63 cents missed the Zacks Consensus Estimate by ...
  7. Agilent Unit & Pfizer Collaborate - Analyst Blog

    February 14, 2013
    Dako, an Agilent Technologies A) subsidiary, has entered into an agreement with Pfizer Inc. (PFE) related to the ...
  8. Life's Products Gain FDA Approval - Analyst Blog

    February 12, 2013
    Global biotechnology tools company - Life Technologies Corporation (LIFE) recently received 510(k) clearance from ...
  9. Data on Biogen Hemophilia Candidates - Analyst Blog

    February 11, 2013
    Biogen Idec (BIIB) and partner, Swedish Orphan Biovitrum recently presented encouraging data on their hemophilia ...
  10. Regal Beloit Buys RAM Motor Business - Analyst Blog

    February 11, 2013
    Regal Beloit Corporation (RBC) recently completed the acquisition of the RAM motor business from Schneider Electric ...
  11. FEI Still A Big Play On The Very Small

    February 11, 2013
    FEI has excellent growth potential, but valuation is a bit steep.
  12. Genomic Beats Estimates - Analyst Blog

    February 08, 2013
    Genomic Health (GHDX) reported fourth-quarter 2012 net income of $2.0 million, down from $2.6 million in the ...
  13. Protalix Exploring Options - Analyst Blog

    February 07, 2013
    Protalix BioTherapeutics, Inc. (PLX) recently confirmed that it has hired Citigroup, Inc. C) to explore strategic ...
  14. Data on Auxilium's Xiaflex - Analyst Blog

    February 07, 2013
    Auxilium Pharmaceuticals, Inc. (AUXL) recently announced that data from the pivotal phase III trials, IMPRESS (The ...
  15. Favorable Ruling for Pfizer - Analyst Blog

    February 07, 2013
    Pfizer Inc. (PFE) recently received a favorable ruling in its patent infringement case against Actavis, Inc. (ACT) ...
  16. Schwab Expands Commission-Free ETF Program - ETF News ...

    February 07, 2013
    Over the past few years, brokerage firms have greatly expanded their lineups of commission-free ETFs. These programs ...
  17. LIFE Beats 4Q Rev, Misses EPS - Analyst Blog

    February 05, 2013
    Life Technologies Corporation (LIFE) reported earnings per share (EPS) of 63 cents in the fourth quarter of fiscal ...
  18. Zoetis Commences Trading - Analyst Blog

    February 04, 2013
    Zoetis Inc. (ZTS), the former Animal Health business of Pfizer Inc. (PFE), started trading on the New York Stock ...
  19. Life Technologies: Preview - Analyst Blog

    February 04, 2013
    Life Technologies (LIFE) is scheduled to report its fourth-quarter and fiscal 2012 results on Monday, Feb 4, 2013, ...
  20. FirstEnergy Submits Rate Info to PSC - Analyst Blog

    January 30, 2013
    FirstEnergy Corporation's (FE) business wings, Mon Power and Potomac Edison, submitted additional rate information ...
Marketplace
Trading Center